2013 ATPAC Annual Meeting
Thailand-U.S. Cooperation:
From R&D to Commercialization
August 29 , 2013
Bangkok, Thailand
Thailand and S&T Related Venture Capital
Noppawan Tanpipat, Ph.D.
Vice President, Innovation Strategy and Partnering
PTT Global Chemical Public Company Limited (PTTGC)
Agenda
Agenda
 PTTGC Business Overview
 A result entity of amalgamation
 Product portfolio and global business
 PTTGC strategic approach to technologies
 Focus of corporate venture capital in innovation process
Strictly Confidential
2
2
Agenda
Agenda
 PTTGC Business Overview
 PTTGC at a glance
 Product portfolio and global business
 PTTGC strategic approach to technologies
 Focus of corporate venture capital in innovation process
Strictly Confidential
3
3
ICIS Top 100 Chemical Companies
Ranking of the world’s largest chemical producers
(listing based on 2011 sales)
Strictly Confidential
4
4
PTTGC: The Chemical Flagship of PTT Group
PTT is the national energy company engaged in conducting an
integrated petroleum and petrochemicals business with the market
capitalization of US$33bn1, ranked as 95th in Fortune 100 company
THE LARGEST OLEFINS
PRODUCER IN THAILAND AND
FIFTH IN ASIA
1
COUNTRIES OPERATING
PETROCHEMICAL CAPACITY
[Million tonnes per annum]
5
EMPLOYEE
•
Polymer producer with the combined production capacity of 3,482 ktpa and
products ranging from HDPE, LLDPE, LDPE, PP, PS and ABS
•
7th largest aromatic producer in Asia with capacity of 3,526ktpa
•
First and sole producer of phenol, acetone, ACN ethylene oxide and related
products in Thailand
•
Business partner with world’s leading companies such as LyondellBasell from
Netherlands, Asahi Kasei Chemical from Japan, Sime Darby Plantation from
Malaysia, Cargill from the US, and Perstorp from Sweden
3531
SALES
[Billion USD]
18.6*
Note: 1) As of 30 March 2012
Strictly Confidential
5
5
Fully Integrated Petrochemical and Refinery Operations with
Diversified Product Portfolio
Strictly Confidential
6
6
Leading chemicals company in South-East Asia with
broadest expertise in downstream derivatives
Strictly Confidential
7
7
Diversified Product Portfolio and End Markets
Strictly Confidential
8
8
Agenda
Agenda
 PTTGC Business Overview
 PTTGC at a glance
 Product portfolio and global business
 PTTGC strategic approach to technologies
 Focus of corporate venture capital in innovation process
Strictly Confidential
9
9
PTTGC Strategic Direction
“To be a Leading Chemical Company
for Better Living”
PTTGC’s
Strategies
1. Enhancing our core uplift
2. Creating long-term value via HVS growth
3. Emerging into green business models
Strictly Confidential
10
10
Global Business: Asia, Europe and US
Strictly Confidential
11
11
page 12
Global Megatrends Impacting Chemical/Plastic Industry
Sustainability
Energy
Conservation
Waste
Reduction
New Materials /
Substitutes
Monomer
Convenience
Polymerization/
Conversion
Compounding
Processing
End Users
“The Trends of Changing World Impact the
Plastics Value Chain in Many Aspect.”
Regulations,
Environment,
and Health
Health &
wellness
Global
Warming
Transportation
Urbanization
Next Billion
Customers &
Rise of Asian
Demand
12
page 13
R&D Development Phase & Gap
Science & Innovation
Innovation and emerging technology acquisition
arms to PTTCG
Source: Modified from BCG Analysis
PTT Chemical
International
13
CVC Agenda
“Green and Transformative”— CVC as an accelerator to
growth beyond current business focus.
Existing
Technology
New
Future business
growth enabled by
new technology
Value
creation
Un-Captured
Captured
Market
Strictly Confidential
14
14
S&I Model To Acquire Emerging Technology
Client or
stakeholder
views
Researcher
interests and
views
Collaboration and Partnering
In-house
R&D
Corporate
strategy
and
priorities
Research
Direct
Investment
Technology
Development
Prototype
and Trial
Joint Development Opportunity
Indirect
Investment
VC
Fund
Portfolio Companies
Technology Incubator
Technology Platform
Corporate venture capital (CVC) as one of strategic technology investment arms
o
Strategic benefits
o
o
o
o
o
Open “window on new technology” through venture investments.
Leverage external sources of innovation through contact with “technology-based investment bankers,
entrepreneurs, scientists, deal finders and makers, consultants and network ”.
Create opportunities in joint development and become strategic partners.
Strengthen entrepreneurial companies’ product marketing through the existing corporate’s marketing experience
and contacts.
Financial benefits
o
o
o
Shorten time and OPEX expenditure in leveraging R&D technology to be commercialized.
Minimize risk and impact from technology failure via indirect investment while managing opportunity of getting
returns on investments upon exit events, such as IPOs or sales to third parties.
Potentially acquire a “right to operate (or produce)” of new and innovative processes (or products) to compete in
their existing market via emerging technology.
Strictly Confidential
15
15
page 16
Unconventional Raw Materials
Crude Oil
Natural Gas
PARADIGM
SHIFT?
1800
1850
1900
1950
2000
Renewable
Resources
Coal
2050
Source: Adapted from BASF
16
page 17
Example: Synthetic Biology
Synthetic biology: Development of new bio-synthetic route to a wide range of products
Source: Technology Strategy Broad, “A synthetic biology roadmap for the UK”
17
page 18
Value Proposition by CVC
Shortcut for Risky technology development and
Commercialization of new emerging innovation at reduced risk.
Client or
stakeholder
views
Researcher
interests
and views
In-house and
Collaborative
R&D
Corporate
strategy
and
priorities
Research
Technology
Development
Joint
development
Prototype
and Trial
Strategic
alliances
Indirect
Investment
CVC
Portfolio Companies
Technology Platform
Technology Incubator
18
Collaboration & Partnering
University
Industry
Government Agency
Strictly Confidential
19
19
page 20
S&I Expansion
Life Science Research Unit
Strictly Confidential
20
Private & Confidential
Thank You
www.pttgcgroup.com
555/1 Energy Complex, Building A, 14th – 18th Floor,
Vibhavadi Rangsit Road, Chatuchak, Bangkok 10900 Thailand.
Telephone : +66 (0) 2265-8400
Fax : +66 (0) 2265-8500